Genomic aberrations relate early and advanced stage ovarian cancer

Cellular Oncology

Volumn 35, Issue 3, 2012, Pages 181-188

  Zaal, Afra ^a   Peyrot, Wouter J ^a   Berns, P M J J ^b,c   Van Der Burg, Maria E L ^b,c   Veerbeek, Jan H W ^a   Trimbos, J Baptist ^d   Cadron, Isabelle ^e   Van Diest, Paul J ^a   Van Wieringen, Wessel N ^f   Krijgsman, Oscar ^f   Meijer, Gerrit A ^f   Piek, Jurgen M J ^a   Timmers, Petra J ^a   Vergote, Ignace ^e   Verheijen, René H M ^a   Ylstra, Bauke ^f   Zweemer, Ronald P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EORTC DATA CENTER   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chromosome aberrations; Neoplasm staging; Oligonucleotide array; Ovarian neoplasms; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; FEMALE; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE-FREE SURVIVAL; FEMALE; GENE DOSAGE; GENOME, HUMAN; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 84870045371     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0077-5     Document Type: Article

References (27)

1. M. Akeson, A.M. Jakobsen, B.M. Zetterqvist, E. Holmberg, M. Brannstrom, G. Horvath, A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors. Int. J. Gynecol. Cancer 19, 116-123 (2009)
2. M. Choi, C.D. Fuller, C.R. Thomas Jr., S.J. Wang, Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol. Oncol. 109, 203-209 (2008)
3. B. Aunoble, R. Sanches, E. Didier, Y.J. Bignon, Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int. J. Oncol. 16, 567-576 (2000)
4. S. Hauptmann, C. Denkert, I. Koch, S. Petersen, K. Schluns, A. Reles, M. Dietel, I. Petersen, Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum. Pathol. 33, 632-641 (2002) (Pubitemid 34827545)
5. J.M. Piek, P. Kenemans, R.H. Verheijen, Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am. J. Obstet. Gynecol. 191, 718-732 (2004) (Pubitemid 39298100)
6. V. Shridhar, J. Lee, A. Pandita, S. Iturria, R. Avula, J. Staub, M. Morrissey, E. Calhoun, A. Sen, K. Kalli, G. Keeney, P. Roche, W. Cliby, K. Lu, R. Schmandt, G.B. Mills, R.C. Bast Jr., C.D. James, F.J. Couch, L.C. Hartmann, J. Lillie, D.I. Smith, Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res. 61, 5895-5904 (2001) (Pubitemid 32769109)
7. R.P. Brosens, J.C. Haan, B. Carvalho, F. Rustenburg, H. Grabsch, P. Quirke, A.F. Engel, M.A. Cuesta, N. Maughan, M. Flens, G.A. Meijer, B. Ylstra, Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J. Pathol. 221, 411-424 (2010)
8. S.J. Smeets, U. Harjes, W.N. van Wieringen, D. Sie, R.H. Brakenhoff, G.A. Meijer, B. Ylstra, To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic! Clin Cancer Res (2011)
9. J.B. Trimbos, I. Vergote, G. Bolis, J.B. Vermorken, C. Mangioni, C. Madronal, M. Franchi, S. Tateo, G. Zanetta, G. Scarfone, L. Giurgea, P. Timmers, C. Coens, S. Pecorelli, Impact of adjuvantchemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J. Natl Cancer Inst. 95, 113-125 (2003) (Pubitemid 36193260)
10. B. Trimbos, P. Timmers, S. Pecorelli, C. Coens, K. Ven, B.M. van der, A. Casado, Surgical staging and treatment of early ovarian cancer: Long-term analysis from a randomized trial. J Natl Cancer Inst (2010)
11. L. Verleye, P.B. Ottevanger, G.B. Kristensen, T. Ehlen, N. Johnson, M.E. van der Burg, N.S. Reed, R.H. Verheijen, K. N. Gaarenstroom, B. Mosgaard, J.M. Seoane, d. van, V, R. Lotocki, G.W. van der, B. Penninckx, C. Coens, G. Stuart, I. Vergote, Quality of pathology reports for advanced ovarian cancer: Are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCICCTG OV13 neoadjuvant trial. Eur J Cancer (2010)
12. M.M. Weiss, M.A. Hermsen, G.A. Meijer, N.C. van Grieken, J.P. Baak, E.J. Kuipers, P.J. van Diest, Comparative genomic hybridisation. Mol. Pathol. 52, 243-251 (1999)
13. T.E. Buffart, D. Israeli, M. Tijssen, S.J. Vosse, A. Mrsic, G.A. Meijer, B. Ylstra, Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations. Genes Chromosomes Cancer 47, 994-1004 (2008)
14. T.E. Buffart, M. Tijssen, T. Krugers, B. Carvalho, S.J. Smeets, R. H. Brakenhoff, H. Grabsch, G.A. Meijer, H.B. Sadowski, B. Ylstra, DNA quality assessment for array CGH by isothermal whole genome amplification. Cell. Oncol. 29, 351-359 (2007) (Pubitemid 47037249)
15. M.A. van deWiel, R. Brosens, P.H. Eilers, C. Kumps, G.A. Meijer, B. Menten, E. Sistermans, F. Speleman, M.E. Timmerman, B. Ylstra, Smoothing waves in array CGH tumor profiles. Bioinformatics 25, 1099-1104 (2009)
16. M.A. van deWiel, K.I. Kim, S.J. Vosse,W.N. vanWieringen, S.M. Wilting, B. Ylstra, CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics 23, 892-894 (2007) (Pubitemid 47049924)
17. A.B. Olshen, E.S. Venkatraman, R. Lucito, M. Wigler, Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557-572 (2004) (Pubitemid 41180205)
18. M.A. van de Wiel, W.N. van Wieringen, CGHregions: dimension reduction for array CGH data with minimal information loss. Cancer Informat. 3, 55-63 (2007) (Pubitemid 47075792)
19. M.A. van de Wiel, S.J. Smeets, R.H. Brakenhoff, B. Ylstra, CGHMultiArray: exact P-values for multi-array comparative genomic hybridization data. Bioinformatics 21, 3193-3194 (2005) (Pubitemid 41418483)
20. I. Scheinin, J.A. Ferreira, S. Knuutila, G.A. Meijer, M.A. van de Wiel, B. Ylstra, CGHpower: exploring sample size calculations for chromosomal copy number experiments. BMC Bioinforma. 11, 331 (2010)
21. S.M. Wilting, S.J. Smeets, P.J. Snijders, W.N. van Wieringen, M. A. van de Wiel, G.A. Meijer, B. Ylstra, C.R. Leemans, C.J. Meijer, R.H. Brakenhoff, B.J. Braakhuis, R.D. Steenbergen, Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck1. BMC Med. Genom. 2, 32 (2009)
22. W.N. van Wieringen, M.A. van de Wiel, B. Ylstra, Weighted clustering of called array CGH data. Biostatistics 9, 484-500 (2008) (Pubitemid 351882087)
23. R Development Core Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Ref Type: Generic (2009)
24. J.P. Geisler, M.J. Goodheart, A.K. Sood, R.J. Holmes, M.A. Hatterman-Zogg, R.E. Buller, Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 98, 2199-2206 (2003) (Pubitemid 37392424)
25. J. Helleman, I. van Staveren, W.N. Dinjens, P.F. van Kuijk, K. Ritstier, P.C. Ewing, M.E. van der Burg, G. Stoter, E.M. Berns, Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer 6, 201 (2006)
26. J. Plisiecka-Halasa, A. nsonka-Mieszkowska, E. Kraszewska, A. nska-Bidzinska, J. Kupryjanczyk, Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas. Anticancer Res. 28, 989-996 (2008) (Pubitemid 351578946)
27. I.M. Shih, R.J. Kurman, Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164, 1511-1518 (2004) (Pubitemid 38529752)